.cls-1{fill:#f55014;}.cls-2{fill:#776e64;} Hem>Investors>The share>Owners Owners Share this: TOP 10 Concentration Country distribution Holding distribution Type distribution Source: Monitor by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority. IRLAB Therapeutics AB (publ) Arvid Wallgrens Backe 20 413 46 Göteborg +46 31 757 38 00 Copyright © 2021 IRLAB Integrity policy

.cls-1{fill:#f55014;}.cls-2{fill:#776e64;} Hem>Investors>The share The share Share this: IRLAB Therapeutics AB (publ) Arvid Wallgrens Backe 20 413 46 Göteborg +46 31 757 38 00 Copyright © 2021 IRLAB Integrity policy

.cls-1{fill:#f55014;}.cls-2{fill:#776e64;} Hem>Investors>Financial calendar Financial calendar Share this: IRLAB’s financial calendar Date Event November 10, 2021 Interim Report Q3, 2021 February 23, 2022 Year-end Report, 2021 April 4-8, 2022 Annual report May 11, 2022 Annual General Meeting May 11, 2022 Interim report January - March 2022 August 24, 2022 Interim report April - June 2022 November 9, 2022 Interim report July - September 2022 February 22, 2023 Year-end Report, 2022 IRLAB Therapeutics AB (publ) Arvid Wallgrens Backe 20 413 46 Göteborg +46 31 757 38 00 Copyright © 2021 IRLAB Integrity policy